✨ Free AI Report
genOway Société anonyme: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research genOway Société anonyme
Company Research

genOway Société anonyme: Business Overview, Financials & Competitive Analysis

genOway Société anonyme scores 6/10 on the AskCyborg Cyborg Score (Solid). Niche biotech with stable customer base and IP strength, but constrained growth trajectory and volatile stock underperformance. Revenue grew to €27.53M in 2024, up 3.85% year-over-year, with earnings increasing 16.79%. However, the company faces headwinds: ALGEN underperformed the French Biotech industry, which returned 316.4% over the past year, and.

What is genOway Société anonyme's industry? genOway Société anonyme (genoway.com) operates in Biotechnology & Medical Research (Preclinical Research Models). AskCyborg classifies genOway Société anonyme under Biotechnology & Medical Research (Preclinical Research Models) in its company registry.

genOway specializes in providing genetically modified mouse and rat models for biopharmaceutical companies, laboratories and research institutes, offering services including site-specific transgenesis, gene deletion, ...

6/ 10Solid

Cyborg Score thesis

Niche biotech with stable customer base and IP strength, but constrained growth trajectory and volatile stock...

Read the full analyst-debate transcript →
Industry Biotechnology & Medical Research (Preclinical Research Models)
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest genOway Société anonyme Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for genOway Société anonyme

AskCyborg analysts argue the bull and bear cases for genOway Société anonyme across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
genOway Société anonyme OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

genOway Société anonyme Overview

Pro stress-test →

genOway specializes in providing genetically modified mouse and rat models for biopharmaceutical companies, laboratories and research institutes, offering services including site-specific transgenesis, gene deletion, humanization, and gene knock-down. The company serves a critical niche in the research and drug development ecosystem.

Strategic Profile

Pro stress-test →

genOway is a market leader building on a broad exclusive technology platform and strong intellectual property combining patents and licensing rights. It has secured commercial contracts with major pharmaceutical leaders (BMS, Janssen, Novartis, Pfizer) and prestigious academic research centers.

Competitive Landscape

Pro stress-test →

genOway operates in a specialized preclinical research models market with limited direct competitors. Major pharmaceutical and biotech companies either develop models in-house or outsource to specialized providers like genOway. The competitive advantage lies in proprietary technology, IP portfolio, and established relationships with pharmaceutical leaders and academic institutions.

Industry Context

genOway Société anonyme operates in Biotechnology & Medical Research (Preclinical Research Models).

Key facts

Founded: 1999 · Headquarters: Lyon, France · Employees: 143-148 · Revenue: €27.53M · Market cap: €22.5M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on genOway Société anonyme.

  • Market leader in genetically modified research models with strong blue-chip customer base including BMS, Janssen, Novartis, and Pfizer
  • Modest but consistent revenue growth (3.85% in 2024) with improving earnings momentum (16.79% growth)
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Mar 2026Stock trading at €2.48, down 7.84% in 24 hours amid broader biotech volatility
  • Feb 2026Market capitalization approximately €22.5M with declining momentum over past week
  • +1 moreTrack every material event for genOway Société anonyme as it happens. Explore monitoring →
Get alerted when genOway Société anonyme has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Custom rodent modelsPreclinical animal models and research services→Transgenic mouse productionLarge pharma with internal transgenic platform→Research models and servicesBroad preclinical services including animal models→

Compare genOway Société anonyme with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

genOway Société anonyme operates in Biotechnology & Medical Research (Preclinical Research Models). See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology & Medical Research (Preclinical Research Models) research →
NEW · MCP server

Ask your AI assistant about genOway Société anonyme

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare genOway Société anonyme and its top competitor on Cyborg Score”
“What did genOway Société anonyme do this quarter?”
“Is genOway Société anonyme a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does genOway Société anonyme do?+
genOway specializes in providing genetically modified mouse and rat models for biopharmaceutical companies, laboratories and research institutes, offering services including site-specific transgenesis, gene deletion, ...
What is genOway Société anonyme's Cyborg Score?+
genOway Société anonyme has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are genOway Société anonyme's main competitors?+
Named competitors include Custom rodent models, Transgenic mouse production, Research models and services. The full competitive landscape is in the AskCyborg report.
How can I get the full genOway Société anonyme research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the genOway Société anonyme research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track genOway Société anonyme over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.